Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

16 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Outcome of chemotherapy in advanced synovial sarcoma patients: Review of 15 clinical trials from the European Organisation for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group; setting a new landmark for studies in this entity.
Vlenterie M, Litière S, Rizzo E, Marréaud S, Judson I, Gelderblom H, Le Cesne A, Wardelmann E, Messiou C, Gronchi A, van der Graaf WT. Vlenterie M, et al. Eur J Cancer. 2016 May;58:62-72. doi: 10.1016/j.ejca.2016.02.002. Epub 2016 Mar 8. Eur J Cancer. 2016. PMID: 26968015
Promising management of pazopanib-induced liver toxicity.
Vlenterie M, van Erp NP, van der Graaf WT. Vlenterie M, et al. Acta Oncol. 2015 Jul;54(7):1064-6. doi: 10.3109/0284186X.2015.1004368. Epub 2015 Mar 3. Acta Oncol. 2015. PMID: 25734660 No abstract available.
Next generation sequencing in synovial sarcoma reveals novel gene mutations.
Vlenterie M, Hillebrandt-Roeffen MH, Flucke UE, Groenen PJ, Tops BB, Kamping EJ, Pfundt R, de Bruijn DR, Geurts van Kessel AH, van Krieken HJ, van der Graaf WT, Versleijen-Jonkers YM. Vlenterie M, et al. Oncotarget. 2015 Oct 27;6(33):34680-90. doi: 10.18632/oncotarget.5786. Oncotarget. 2015. PMID: 26415226 Free PMC article.
Phosphoproteomic Profiling Reveals ALK and MET as Novel Actionable Targets across Synovial Sarcoma Subtypes.
Fleuren EDG, Vlenterie M, van der Graaf WTA, Hillebrandt-Roeffen MHS, Blackburn J, Ma X, Chan H, Magias MC, van Erp A, van Houdt L, Cebeci SAS, van de Ven A, Flucke UE, Heyer EE, Thomas DM, Lord CJ, Marini KD, Vaghjiani V, Mercer TR, Cain JE, Wu J, Versleijen-Jonkers YMH, Daly RJ. Fleuren EDG, et al. Among authors: vlenterie m. Cancer Res. 2017 Aug 15;77(16):4279-4292. doi: 10.1158/0008-5472.CAN-16-2550. Epub 2017 Jun 20. Cancer Res. 2017. PMID: 28634201
Expression and clinical relevance of MET and ALK in Ewing sarcomas.
Fleuren ED, Roeffen MH, Leenders WP, Flucke UE, Vlenterie M, Schreuder HW, Boerman OC, van der Graaf WT, Versleijen-Jonkers YM. Fleuren ED, et al. Among authors: vlenterie m. Int J Cancer. 2013 Jul 15;133(2):427-36. doi: 10.1002/ijc.28047. Epub 2013 Feb 25. Int J Cancer. 2013. PMID: 23335077
Anti-angiogenic therapy, a new player in the field of sarcoma treatment.
Versleijen-Jonkers YM, Vlenterie M, van de Luijtgaarden AC, van der Graaf WT. Versleijen-Jonkers YM, et al. Among authors: vlenterie m. Crit Rev Oncol Hematol. 2014 Aug;91(2):172-85. doi: 10.1016/j.critrevonc.2014.02.001. Epub 2014 Feb 15. Crit Rev Oncol Hematol. 2014. PMID: 24613529 Review.
Positron emission tomography response criteria in solid tumours criteria for quantitative analysis of [18F]-fluorodeoxyglucose positron emission tomography with integrated computed tomography for treatment response assessment in metastasised solid tumours: All that glitters is not gold.
Willemsen AECAB, Vlenterie M, van Herpen CML, van Erp NP, van der Graaf WTA, de Geus-Oei LF, Oyen WJG. Willemsen AECAB, et al. Among authors: vlenterie m. Eur J Cancer. 2016 Mar;56:54-58. doi: 10.1016/j.ejca.2015.12.017. Epub 2016 Jan 22. Eur J Cancer. 2016. PMID: 26808297
16 results